on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation..
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital...